Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands.

Source:http://linkedlifedata.com/resource/pubmed/id/20068181

Cancer Res. 2010 Jan 15 70 2 490-500

Download in:

View as

Triples

General Info

PMID
20068181